ClinicalTrials.Veeva

Menu

High Flow Oxygen Therapy Effect on Healthy Subjects

A

Argentinian Intensive Care Society

Status

Completed

Conditions

Diaphragm
Healthy Volunteers
Respiratory Rate

Treatments

Device: High flow nasal canula

Study type

Interventional

Funder types

Other

Identifiers

NCT06086769
CRIHB #1220 PRISA No. 6256

Details and patient eligibility

About

The use of high-flow nasal cannula (HFNC) has increased. Diaphragmatic ultrasonography is a tool that, as a noninvasive complement to esophageal pressure (Pes) measurement, allows the evaluation of diaphragm function and reflects, through the diaphragm thickening fraction (DTf), the magnitude of diaphragmatic fiber recruitment. The objective of this study was to evaluate the impact of HFNC therapy on the DTf in healthy subjects. Second, this study aimed to assess the behavior of the respiratory rate (RR) and the work of breathing in these subjects.

Enrollment

13 patients

Sex

All

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy subjects over 18 years old

Exclusion criteria

  • contraindication for esophageal balloon placement
  • diagnosis of lung disease
  • smokers

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems